Variables used in the calculation of relevant prognostic scores
| . | IPI20 . | PIT21 . | m-PIT22 . | ITCLP23 . |
|---|---|---|---|---|
| Age (>60 y) | ● | ● | ● | ● |
| ECOG (>1) | ● | ● | ● | ● |
| LDH (elevated values) | ● | ● | ● | |
| Ann Arbor stage (III-IV) | ● | |||
| Extranodal involvement (≥2 sites) | ● | |||
| Bone marrow involvement | ● | |||
| Platelet count (<150 000/mmc) | ● | |||
| Ki-67 (≥80%) | ● |
| . | IPI20 . | PIT21 . | m-PIT22 . | ITCLP23 . |
|---|---|---|---|---|
| Age (>60 y) | ● | ● | ● | ● |
| ECOG (>1) | ● | ● | ● | ● |
| LDH (elevated values) | ● | ● | ● | |
| Ann Arbor stage (III-IV) | ● | |||
| Extranodal involvement (≥2 sites) | ● | |||
| Bone marrow involvement | ● | |||
| Platelet count (<150 000/mmc) | ● | |||
| Ki-67 (≥80%) | ● |